Atrial natriuretic peptide inhibits cardiomyocyte hypertrophy through mitogen-activated protein kinase phosphatase-1.
Doubun Hayashi a, b, Sumiyo Kudoh a, Ichiro Shiojima a, Yunzeng Zou d, Koichiro Harada a, Masaki Shimoyama a, Yasushi Imai a, Koshiro Monzen a, b, Tsutomu Yamazaki a, c, Yoshio Yazaki e, Ryozo Nagai a, Issei Komuro d
Source
Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
- a Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan
- b Department of Pharmacoepidemiology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan
- c Department of Clinical Bioinformatics, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan
- d Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan
- e International Medical Center of Japan, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan
Fig. 2A
c-fosのANPと8-Bromoのバンドも左右反転して横にちょっと拡大？
Fig. 2A
18SのANPと8-Bromoのバンドが類似： 横にちょっと拡大？
Fig. 2B
28S Line 1 = 28S Line 4
28S Line 2 = 28S Line 5
28S Line 3 = 28S Line 6
28S Line 1 = 28S Line 4
28S Line 2 = 28S Line 5
28S Line 3 = 28S Line 6
0 件のコメント:
コメントを投稿